Biomarkers of Inflammatory Bowel Disease

被引：63
|
作者：
Yi Fengming [1 ]
Wu Jianbing [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang 330006, Jiangxi, Peoples R China
来源：
DISEASE MARKERS | 2014年 / 2014卷
关键词：
SACCHAROMYCES-CEREVISIAE ANTIBODIES; ACTIVE ULCERATIVE-COLITIS; FECAL PYRUVATE-KINASE; MEAN PLATELET VOLUME; C-REACTIVE PROTEIN; CROHNS-DISEASE; INTESTINAL INFLAMMATION; NONINVASIVE MARKER; DIAGNOSTIC-VALUE; INDETERMINATE COLITIS;
D O I：
10.1155/2014/710915
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.
引用
收藏
页数：11
相关论文
共 50 条
  • [11] New serological biomarkers of inflammatory bowel disease
    Laurie Conklin
    Philip Alex
    World Journal of Gastroenterology, 2008, (33) : 5115 - 5124
  • [12] New serological biomarkers of inflammatory bowel disease
    Li, Xuhang
    Conklin, Laurie
    Alex, Philip
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (33) : 5115 - 5124
  • [13] Biomarkers in inflammatory bowel disease: a practical guide
    Clough, Jennie
    Colwill, Michael
    Poullis, Andrew
    Pollok, Richard
    Patel, Kamal
    Honap, Sailish
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [14] Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
    Duvoisin, Gilles
    Lopez, Robert N.
    Day, Andrew S.
    Lemberg, Daniel A.
    Gearry, Richard B.
    Leach, Steven T.
    MEDIATORS OF INFLAMMATION, 2017, 2017 : 1 - 9
  • [15] Novel biomarkers associated with inflammatory bowel disease
    Baldan-Martin, M.
    Lloro, I.
    Azkargorta, M.
    Orejudo, M.
    Ramirez, C.
    Soleto, I.
    Mercado, J.
    Suarez-Trujillo, F.
    Sanchez-Sanchez, C.
    Gordillo-Velez, C. H.
    Riestra, S.
    Rivero, M.
    Gutierrez, A.
    Rodriguez-Lago, I.
    Fernandez-Salazar, L.
    Ceballos, D.
    Benitez, J. M.
    Aguas, M.
    Rey, I. Baston
    Bermejo, F.
    Casanova, M. J.
    Lorente, R.
    Ber, Y.
    Royo, V.
    Esteve, M.
    Elortza, F.
    Gisbert, J. P.
    Chaparro, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I483 - I484
  • [16] Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
    Sakurai, Toshiyuki
    Saruta, Masayuki
    DIGESTION, 2023, 104 (01) : 30 - 41
  • [17] Biomarkers in canine inflammatory bowel disease diagnostics
    Wdowiak, M.
    Rychlik, A.
    Kolodziejska-Sawerska, A.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2013, 16 (03): : 601 - 610
  • [18] Utility of Biomarkers in the Management of Inflammatory Bowel Disease
    Gursimran Kochhar
    Bret Lashner
    Current Treatment Options in Gastroenterology, 2017, 15 (1) : 105 - 115
  • [19] Review of fecal biomarkers in inflammatory bowel disease
    Sutherland, Andrew D.
    Gearry, Richard B.
    Frizelle, Frank A.
    DISEASES OF THE COLON & RECTUM, 2008, 51 (08) : 1283 - 1291
  • [20] A glycomic approach to the identification of disease biomarkers in inflammatory bowel disease
    Roy, P.
    Alavi, A.
    Fraser, O.
    Tarelli, E.
    Axford, J.
    Kumar, D.
    GUT, 2007, 56 : A119 - A119
12345